Xin-fu F. Zhou

101 Currie Street
Adelaide, SA 5001, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications

Correction: p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's disease.

Correction: p75NTR ectodomain is a physiological neuroprotective molecule against amyloid-beta toxicity in the brain of Alzheimer's disease.

Journal: Molecular psychiatry
Published: December 11, 2025

p75ECD-Fc reverses neonatal hypoxic-ischemic encephalopathy-induced neurological deficits and inhibits apoptosis associated with Nestin.

p75ECD-Fc reverses neonatal hypoxic-ischemic encephalopathy-induced neurological deficits and inhibits apoptosis associated with Nestin.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 28, 2023

Neuroprotection of Oral Edaravone on Middle Cerebral Artery Occlusion in Rats.

Neuroprotection of Oral Edaravone on Middle Cerebral Artery Occlusion in Rats.

Journal: Neurotoxicity research
Published: January 18, 2022

Novel oral edaravone attenuates diastolic dysfunction of diabetic cardiomyopathy by activating the Nrf2 signaling pathway.

Novel oral edaravone attenuates diastolic dysfunction of diabetic cardiomyopathy by activating the Nrf2 signaling pathway.

Journal: European journal of pharmacology
Published: October 29, 2021

Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia.

Preclinical validation of a novel oral Edaravone formulation for treatment of frontotemporal dementia.

Journal: Neurotoxicity research
Published: May 10, 2021

Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice.

Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice.

Journal: Metabolic brain disease
Published: April 26, 2021

Pharmacokinetic Modelling of Human Recombinant Protein, p75ECD-Fc: A Novel Therapeutic Approach for Treatment of Alzheimer's Disease, in Serum and Tissue of Sprague Dawley Rats.

Pharmacokinetic Modelling of Human Recombinant Protein, p75ECD-Fc: A Novel Therapeutic Approach for Treatment of Alzheimer's Disease, in Serum and Tissue of Sprague Dawley Rats.

Journal: European journal of drug metabolism and pharmacokinetics
Published: November 13, 2020

A New Approach to Model Sporadic Alzheimer's Disease by Intracerebroventricular Streptozotocin Injection in APP/PS1 Mice.

A New Approach to Model Sporadic Alzheimer's Disease by Intracerebroventricular Streptozotocin Injection in APP/PS1 Mice.

Journal: Molecular neurobiology
Published: August 15, 2020

ESCAPE-NA1 Trial Brings Hope of Neuroprotective Drugs for Acute Ischemic Stroke: Highlights of the Phase 3 Clinical Trial on Nerinetide.

ESCAPE-NA1 Trial Brings Hope of Neuroprotective Drugs for Acute Ischemic Stroke: Highlights of the Phase 3 Clinical Trial on Nerinetide.

Journal: Neuroscience bulletin
Published: July 20, 2020

Negative regulation by proBDNF signaling of peripheral neurogenesis in the sensory ganglia of adult rats.

Negative regulation by proBDNF signaling of peripheral neurogenesis in the sensory ganglia of adult rats.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 17, 2020

Neuroprotective Effects of Anti-proBDNF in a Rat Photothrombotic Ischemic Model.

Neuroprotective Effects of Anti-proBDNF in a Rat Photothrombotic Ischemic Model.

Journal: Neuroscience
Published: May 10, 2020

Downregulation of Adhesion Molecule CHL1 in B Cells but Not T Cells of Patients with Major Depression and in the Brain of Mice with Chronic Stress.

Downregulation of Adhesion Molecule CHL1 in B Cells but Not T Cells of Patients with Major Depression and in the Brain of Mice with Chronic Stress.

Journal: Neurotoxicity research
Published: April 30, 2020
Showing 1-12 of 40

Last Updated: 09/26/2026